ArticleMediterranean journal of hematology and infectious diseases2022
Management of Relapsed/Refractory All with Inotuzumab During COVID-19. A Case Report.
Martina Di Palma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this paperpooled itcites it